361 related articles for article (PubMed ID: 24561863)
1. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
2. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide.
Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584
[TBL] [Abstract][Full Text] [Related]
3. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids.
Kandhi S; Zhang B; Froogh G; Qin J; Alruwaili N; Le Y; Yang YM; Hwang SH; Hammock BD; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L350-L359. PubMed ID: 28450284
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats.
Huang Y; Qin J; Sun D; Jiang H; Zheng L; He Y; Gui L; Qian B; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():17-24. PubMed ID: 28473204
[TBL] [Abstract][Full Text] [Related]
6. Sexually dimorphic phenotype of arteriolar responsiveness to shear stress in soluble epoxide hydrolase-knockout mice.
Qin J; Kandhi S; Froogh G; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1860-6. PubMed ID: 26453332
[TBL] [Abstract][Full Text] [Related]
7. Contribution of 20-HETE to augmented myogenic constriction in coronary arteries of endothelial NO synthase knockout mice.
Huang A; Sun D; Yan C; Falck JR; Kaley G
Hypertension; 2005 Sep; 46(3):607-13. PubMed ID: 16043660
[TBL] [Abstract][Full Text] [Related]
8. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.
Hercule HC; Schunck WH; Gross V; Seringer J; Leung FP; Weldon SM; da Costa Goncalves ACh; Huang Y; Luft FC; Gollasch M
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):54-60. PubMed ID: 18927469
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
10. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.
Kopkan L; Husková Z; Sporková A; Varcabová Š; Honetschlägerová Z; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Kramer HJ; Bürgelová M; Vojtíšková A; Kujal P; Vernerová Z; Červenka L
Kidney Blood Press Res; 2012; 35(6):595-607. PubMed ID: 22948718
[TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.
Vanella L; Canestraro M; Lee CR; Cao J; Zeldin DC; Schwartzman ML; Abraham NG
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():139-47. PubMed ID: 25908301
[TBL] [Abstract][Full Text] [Related]
17. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250
[TBL] [Abstract][Full Text] [Related]
18. Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.
Huang A; Sun D
Front Pharmacol; 2018; 9():1222. PubMed ID: 30420806
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
